Legend Biotech (LEGN) Depreciation and Depletion (2020 - 2025)

Legend Biotech's Depreciation and Depletion history runs 6 years deep, the most recent figure standing at $2.1 million for Q3 2025.

• Quarterly Depreciation and Depletion fell 9.87% year-over-year to $2.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $9.5 million (down 11.49% YoY) and the FY2024 annual result came in at $10.7 million, changed 0.04% from the prior year.
• Depreciation and Depletion was $2.1 million for Q3 2025 at Legend Biotech, down from $2.3 million in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $3.2 million in Q1 2022 and bottomed at -$20000.0 in Q4 2021.
• A 5-year average of $2.4 million and a median of $2.7 million in 2023 frame the typical range for Depreciation and Depletion.
• Peak annual rise in Depreciation and Depletion reached 12505.0% in 2022, while the deepest fall reached 38.93% in 2022.
• Legend Biotech's Depreciation and Depletion stood at -$20000.0 in 2021, then surged by 12505.0% to $2.5 million in 2022, then climbed by 9.88% to $2.7 million in 2023, then increased by 0.62% to $2.7 million in 2024, then retreated by 21.76% to $2.1 million in 2025.
• Business Quant data shows LEGN's Depreciation and Depletion at $2.1 million in Q3 2025, $2.3 million in Q2 2025, and $2.3 million in Q1 2025.